BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed SOGP catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:09a6c01f71bae9c289fb@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:SOGP P2 readout (est.): SPI-1005 in Adults Receiving Cochlear Impla
 nt
DESCRIPTION:SPI-1005 in Adults Receiving Cochlear Implant\nNCT06340633 | PH
 ASE2 | RECRUITING | sponsor: Sound Pharmaceuticals\, Incorporated\nPrimary
  completion date (ESTIMATED)\; top-line results usually follow later.\nDat
 e precision: month (shown on the first day)\nTicker SOGP (confidence 0.9)\
 nSource: https://clinicaltrials.gov/study/NCT06340633\nScheduling/referenc
 e data from public records\; dates can move. Not investment\, legal or med
 ical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06340633
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:cc4fb88f346966999be6@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:SOGP P3 readout (est.): SPI-1005 for the Treatment of Meniere's Dis
 ease (Open Label)
DESCRIPTION:SPI-1005 for the Treatment of Meniere's Disease (Open Label)\nN
 CT06859788 | PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Sound Pharmaceutica
 ls\, Incorporated\nPrimary completion date (ESTIMATED)\; top-line results 
 usually follow later.\nDate precision: month (shown on the first day)\nTic
 ker SOGP (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT068
 59788\nScheduling/reference data from public records\; dates can move. Not
  investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06859788
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
